Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 49,522 | 47,819 | 32,470 | 34,464 | 34,581 |
| Cost of Goods | 38,578 | 34,496 | 23,875 | 22,394 | 22,599 |
| Gross Profit | 10,944 | 13,323 | 8,596 | 12,070 | 11,982 |
| Operating Expenses | 35,160 | 44,872 | 32,607 | 25,793 | 20,564 |
| Operating Income | -23,638 | -31,053 | -23,136 | -13,329 | -7,983 |
| Interest Expense | 2,813 | 2,912 | 2,842 | 847 | 0 |
| Other Income | 3,195 | 0 | 0 | 0 | 50 |
| Pre-tax Income | -23,256 | -33,966 | -25,978 | -14,175 | -7,933 |
| Income Tax | 34 | -62 | -457 | -500 | -68 |
| Net Income Continuous | -23,291 | -33,904 | -25,521 | -13,675 | -7,866 |
| Net Income | $-23,291 | $-33,904 | $-25,521 | $-13,675 | $-7,866 |
| EPS Basic Total Ops | -0.72 | -1.40 | -1.34 | -0.81 | -0.54 |
| EPS Basic Continuous Ops | -0.72 | -1.40 | -1.34 | -0.81 | -0.55 |
| EPS Diluted Total Ops | -0.72 | -1.40 | -1.34 | -0.81 | -0.54 |
| EPS Diluted Continuous Ops | -0.72 | -1.40 | -1.34 | -0.81 | -0.55 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.11 | -1.28 | -0.79 | -0.55 |
| EBITDA(a) | $-21,085 | $-28,122 | $-20,439 | $-11,412 | $-7,080 |